NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
52 hedge funds and large institutions have $40.1M invested in NexImmune, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
13% more funds holding
Funds holding: 46 → 52 (+6)
15% less capital invested
Capital invested by funds: $47.1M → $40.1M (-$6.95M)
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$560K |
| 2 |
BBHC
Brown Brothers Harriman & Co
New York
|
+$361K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$279K |
| 4 |
CG
Caprock Group
Boise,
Idaho
|
+$166K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.4M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$998K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$800K |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$461K |
| 5 |
Millennium Management
New York
|
-$284K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $5K | -$13.1K | -178 | -78% |
|
52
Citigroup
New York
| $5K | -$9.62K | -131 | -72% |
|
|
TCM
53
TimesSquare Capital Management
New York
| – | -$998K | -8,656 | Closed |
|
|
JMPWA
54
JP Morgan Private Wealth Advisors
San Francisco,
California
| – | -$461K | -4,000 | Closed |
|
|
55
Millennium Management
New York
| – | -$284K | -2,467 | Closed |
|
56
D.E. Shaw & Co
New York
| – | -$70K | -609 | Closed |
|
57
Two Sigma Investments
New York
| – | -$59K | -510 | Closed |
|
|
HNWAG
58
High Net Worth Advisory Group
Naples,
Florida
| – | -$2K | -20 | Closed |
|
NEXI Hedge Fund Activity: Q1 2022 in Review
52 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q1 2022, worth a combined $40.1M — down 15% from $47.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NEXI positions and 6 closed out — a net gain of 6 holders — while 7 added to existing stakes and 17 trimmed.
The largest buyer was EPIQ Capital Group, opening a new position worth an estimated $560K. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $1.4M.
- 52 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q1 2022, up from 46 in Q4 2021.
- Funds reported $40.1M of NexImmune, Inc. Common Stock stock for Q1 2022, down 15% quarter-over-quarter.
- 12 funds opened new NexImmune, Inc. Common Stock positions in Q1 2022 and 6 closed out, a net change of +6 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q1 2022 was EPIQ Capital Group, an estimated $560K added.
- The largest NexImmune, Inc. Common Stock seller in Q1 2022 was ArrowMark Colorado Holdings, an estimated $1.4M sold.
Based on aggregated 13F filings for Q1 2022.